Organigram Global

OGI · TORONTO

$0.9262−$0.0104 (−1.11%)TodayMarket closed ·
Prev close $0.9366

About OGI

Organigram Global, Inc. engages in the provision of high-quality, indoor-grown cannabis for patients and adult recreational consumers and developing international business partnerships to extend the company’s global footprint. The company is headquartered in Moncton, New Brunswick and currently employs 1,137 full-time employees. The company went IPO on 2011-11-24. The company has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. The company operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. The company operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.

Employees
1,137
Headquarters
Moncton, New Brunswick
Listed
Nov 24, 2011
Sector
Health Care
Industry
Pharmaceuticals

OGI key statistics

Market cap
183.31M
Price-earnings ratio
2.17
Dividend yield
—
Average volume
415.56K
Volume
189.30K
Open price
$0.9299
High today
$0.9529
Low today
$0.921
52 Week high
$2.24
52 Week low
$0.8531

Organigram Global (OGI) at a glance

Organigram Global (OGI) last traded at $0.9262, with a market cap of 183.31M and a price-to-earnings ratio of 2.17.

Today the stock has traded between $0.921 and $0.9529. The current price is 0.6% above the day's low and 2.8% below its high.

Volume so far is 189.30K shares, below the average of 415.56K shares a day.

Over the past year Organigram Global has ranged from $0.8531 to $2.24, and now sits 5% of the way up that range.

Organigram Global met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q3 FY26 it reported $0.03 per share against an estimate of -$0.0027.

OGI earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 911.2% on average.

  1. Q4 FY24: reported -$0.092 per share against an estimate of -$0.0404
  2. Q1 FY25: reported -$0.202 per share against an estimate of -$0.0404
  3. Q2 FY25: reported $0.33 per share against an estimate of -$0.0404
  4. Q3 FY25: reported -$0.04 per share against an estimate of -$0.0152
  5. Q4 FY25: reported -$0.33 per share against an estimate of -$0.0126
  6. Q1 FY26: reported $0.14 per share against an estimate of -$0.0101
  7. Q2 FY26: reported -$0.007 per share against an estimate of -$0.0101
  8. Q3 FY26: reported $0.03 per share against an estimate of -$0.0027

OGI news

  • Press releaseBusiness Wire

    Organigram Provides Update on Integration of Sanity Group and Unified Global Operating Model

  • Press releaseBusiness Wire

    Organigram Global to Premiere The 2026 OG Investor Session Today at 4:00 p.m. ET on X

  • Press releaseBusiness Wire

    Organigram Global to Host 2026 OG Investor Session

  • Press releaseBusiness Wire

    Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure

  • 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • Press releaseBusiness Wire

    Organigram Reports Record Third Quarter Fiscal 2026 Results

  • Press releaseBusiness Wire

    Organigram to Report Third Quarter Fiscal 2026 Results on August 11, 2026

  • Press releaseBusiness Wire

    Organigram Provides Business Update Highlighting Initial Sanity Performance and Canadian Market Share

Similar companies

Companies in the same industry as Organigram Global

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.